| Wellone Primary Medical And Dental Care | |
|
308 Callahan Rd N. Kingstown RI 02852-7739 | |
| (401) 295-9706 | |
| (401) 295-0920 |
| Full Name | Wellone Primary Medical And Dental Care |
|---|---|
| Speciality | Clinic/Center |
| Location | 308 Callahan Rd, N. Kingstown, Rhode Island |
| Authorized Official Name and Position | Peter J. Bancroft (PRESIDENT & CEO) |
| Authorized Official Contact | 4012855119 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Wellone Primary Medical And Dental Care Po Box 312 Pascoag RI 02859 Ph: (401) 568-7664 | Wellone Primary Medical And Dental Care 308 Callahan Rd N. Kingstown RI 02852-7739 Ph: (401) 295-9706 |
| NPI Number | 1801951397 |
|---|---|
| Provider Enumeration Date | 12/26/2006 |
| Last Update Date | 10/21/2011 |
| Medicare PECOS PAC ID | 1355250663 |
|---|---|
| Medicare Enrollment ID | O20050308000422 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801951397 | NPI | - | NPPES |
| NC50602 | Medicaid | RI | |
| BS41305 | Medicaid | RI | |
| BS41307 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | ACF01530 (Rhode Island) | Secondary |
| 261QC1500X | Clinic/center - Community Health | ACF01597 (Rhode Island) | Primary |
| Provider Name | Joan K Mullaney |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588611503 PECOS PAC ID: 6305820713 Enrollment ID: I20040615000199 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Linda Eibel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386657096 PECOS PAC ID: 9830167741 Enrollment ID: I20040920000206 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Clifford I Gordon |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1942306675 PECOS PAC ID: 8729039987 Enrollment ID: I20050204000110 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Mary L Giovetti |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1720180367 PECOS PAC ID: 8224082680 Enrollment ID: I20050309000003 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Steven Diehl |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1215988175 PECOS PAC ID: 7214985779 Enrollment ID: I20051201000461 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Joanna Brown |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1720059025 PECOS PAC ID: 0345322418 Enrollment ID: I20080128000783 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Barry J Giordano |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1346386646 PECOS PAC ID: 2961442793 Enrollment ID: I20111014000324 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Leonard Anthony Mannarelli |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982770764 PECOS PAC ID: 3274693536 Enrollment ID: I20120227000719 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Desirae Heys |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316381205 PECOS PAC ID: 7810137940 Enrollment ID: I20130712000179 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Dayna Orourke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053488379 PECOS PAC ID: 7618105743 Enrollment ID: I20140116000657 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Elizabeth A Sherman |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1730595893 PECOS PAC ID: 5092933937 Enrollment ID: I20140905001673 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Stephanie Pinto |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235548371 PECOS PAC ID: 8820210743 Enrollment ID: I20141110001046 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Jennifer Ugbanaja |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1043646128 PECOS PAC ID: 2062738560 Enrollment ID: I20150227000687 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Nicole Coggins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356723548 PECOS PAC ID: 5193031938 Enrollment ID: I20150825003628 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Saima Kane |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841686052 PECOS PAC ID: 3971812975 Enrollment ID: I20151014000071 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Nicole D. Burns |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235597139 PECOS PAC ID: 4385942259 Enrollment ID: I20160408000651 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Erica L Magaziner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497130744 PECOS PAC ID: 7113235409 Enrollment ID: I20170512000111 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Steven Joel Hershey |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1831120260 PECOS PAC ID: 0143506345 Enrollment ID: I20170615001118 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Ryan Heney |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528447182 PECOS PAC ID: 8527371087 Enrollment ID: I20181002002214 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Charles D Fraser |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184101610 PECOS PAC ID: 5890048219 Enrollment ID: I20181031001994 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Michala Jorrin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255784005 PECOS PAC ID: 3375812076 Enrollment ID: I20181119001917 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Missy Buco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306318290 PECOS PAC ID: 5799022893 Enrollment ID: I20190128002945 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Alice Mui |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275032476 PECOS PAC ID: 8729312376 Enrollment ID: I20190702000266 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Stephanie Forget |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346623691 PECOS PAC ID: 8325349087 Enrollment ID: I20201120002370 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Michelle L Fox |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003243148 PECOS PAC ID: 7315160504 Enrollment ID: I20210810003084 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Amanda Marie Gould |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437633435 PECOS PAC ID: 8224427596 Enrollment ID: I20211109000469 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | John Paul Carvalho |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1033375829 PECOS PAC ID: 9436549896 Enrollment ID: I20211130000636 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Tina Marie Parker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386237154 PECOS PAC ID: 2769860147 Enrollment ID: I20220526001796 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Yolanda Dasilva-melo |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1255864443 PECOS PAC ID: 6507240561 Enrollment ID: I20220825001630 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Garrett S Bowen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1619505385 PECOS PAC ID: 8123442126 Enrollment ID: I20230920001388 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Marie Amelia Capobianco |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1306285143 PECOS PAC ID: 0941652887 Enrollment ID: I20240117000375 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Maureen Day O'shea |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1477856490 PECOS PAC ID: 2668824368 Enrollment ID: I20240118001349 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Melissa Sabatini |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1740727650 PECOS PAC ID: 7517319767 Enrollment ID: I20240123004349 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
| Provider Name | Amy E Sweet |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1629201967 PECOS PAC ID: 6800249624 Enrollment ID: I20240129002378 |
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago
News Archive
GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A growing number of drugs are being approved on the basis of indirect ('surrogate') measures that do not always reliably predict outcomes that matter most to patients, such as living longer or feeling better.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
A study of women who were new mothers in the late 1970s found that those who were given longer, paid maternity leave lived healthier lives as they entered middle age.
› Verified 7 days ago